Obesity Is a Chronic Disease — Here's How Clinicians Actually Think About It
From ABCD staging to the biology of weight regain, the clinical model of obesity has shifted — and it changes everything about your care.
Great — I have strong sourcing across the AACE clinical framework, the biology of weight regain, stigma research, and the WHO/chronic disease recognition angle. Let me write the article now.
Most people think of obesity as a number on a scale. Their doctor might think of it very differently.
The shift happening inside clinical medicine right now — from "lose some weight" to "manage a chronic, relapsing disease" — changes everything about how you should expect to be treated, what tools are on the table, and why the weight kept coming back before.
It's officially a disease. That actually matters.
MedlinePlus (NIH) defines obesity as a disease — not a lifestyle failure, not a character flaw. A BMI of 30 or higher meets the threshold, but clinicians increasingly look well past that single number.
In December 2025, the World Health Organization formally recognized obesity as a disease treatable with GLP-1 medications, a move Boston University called a "big deal" for how it reshapes access to treatment globally. That's not a small thing. Official disease classification affects insurance coverage, prescribing guidelines, and — critically — how much blame gets placed on you.
The "ABCD" framework: how endocrinologists actually stage it
In 2017, the American Association of Clinical Endocrinologists introduced a term most people have never heard: Adiposity-Based Chronic Disease, or ABCD. According to the position statement published in Endocrine Practice, the term was designed to move the clinical conversation away from weight as a cosmetic issue and toward fat tissue as a driver of measurable organ damage — think type 2 diabetes, hypertension, sleep apnea, and fatty liver.
In 2025, AACE updated its treatment algorithm. The 2025 consensus statement in Endocrine Practice outlines how clinicians should now evaluate and treat adults using a staged approach — meaning treatment intensity is matched to disease severity, not just to how much someone weighs. That's the same logic used for heart disease or cancer staging.
The practical upshot: two people with the same BMI can be at very different stages of disease and warrant very different interventions.
Your body fights back — and that's biology, not weakness
Here's the part that most diet culture gets completely wrong. When you lose weight, your body doesn't just sit quietly and accept the new number.
Research published in the Journal of Internal Medicine on metabolic and appetitive regulation during obesity treatment describes how hormonal and metabolic signals — including appetite-regulating hormones from fat tissue — actively work to restore lost weight. This is the biological basis of the "set point" concept: your body has defended a higher weight for years, and it will deploy hunger signals, slow metabolism, and hormonal shifts to get back there.
A 2023 Lancet review of contemporary obesity therapies frames this directly — effective long-term management requires ongoing intervention precisely because the biology of weight regain is persistent. That's not a moral failing. That's a chronic disease behaving like a chronic disease.
The stigma problem — and why it shows up in your care
Weight stigma isn't just socially uncomfortable. According to a study in Obesity Reviews, weight bias in healthcare settings is associated with worse quality of care and worse outcomes for people with obesity. Clinicians with implicit bias may spend less time, offer fewer diagnostic workups, or default to "just eat less" — regardless of what the science says.
A 2020 joint international consensus statement in Nature Medicine, signed by dozens of researchers and clinicians worldwide, called explicitly for ending the stigma of obesity and reframing it as a chronic, multifactorial disease. And a 2025 standards-of-care paper in BMJ Open Diabetes Research & Care reinforced that addressing weight stigma is now considered part of clinical best practice, not a soft add-on.
If you've ever walked out of a doctor's office feeling dismissed, this research is why advocates are pushing hard to change that dynamic.
What "chronic disease management" actually looks like
The word "chronic" carries a specific clinical meaning: you don't cure it, you manage it. The same way someone with hypertension stays on medication long-term, the 2025 AACE algorithm and a 2025 weight management review in Medicina Clínica both emphasize that treatment for obesity — whether that's lifestyle therapy, pharmacotherapy, or surgery — is typically a long-term commitment, not a short course.
That framing matters for you practically. It means:
- Stopping a medication because you "hit your goal" is roughly equivalent to stopping blood pressure medication because your BP looks good today.
- A plateau or partial regain isn't failure — it's the disease behaving predictably, and it's a signal to reassess the treatment plan.
- The goal isn't a number. It's reducing the health burden the disease is causing.
What this means for you
- You are not the problem. The biology of obesity — hormones, metabolic adaptation, fat tissue signaling — is well-documented. Clinicians who understand this will treat you accordingly.
- Ask your provider how they're staging your disease, not just tracking your BMI. A good obesity medicine conversation includes your metabolic health markers, not just the scale.
- Long-term treatment is normal. If your plan requires ongoing support, medication, or monitoring, that's not a sign you're doing it wrong — it's a sign your provider is treating this like the chronic disease it is.
Not medical advice. Talk to your prescriber about your specific situation, treatment options, and what's right for you.
